Question 1

What is HUM stock price today?

Accepted Answer

Humana Inc. (HUM) is currently trading at $393.89, down 3.79% today.

Question 2

What is HUM market cap?

Accepted Answer

Humana Inc. has a market capitalization of $49 billion, making it one of the notable companies in the Healthcare sector.

Question 3

What is HUM P/E ratio?

Accepted Answer

Humana Inc. has a P/E ratio of 42.13, which measures the stock price relative to its earnings per share.

Question 4

What is HUM price target?

Accepted Answer

The average analyst price target for Humana Inc. is $280.65, which represents a -28.7% downside from the current price.

Question 5

What is HUM 52-week high and low?

Accepted Answer

Humana Inc.'s 52-week high is $415.00 and 52-week low is $163.11. The current price of $393.89 is 92% of its 52-week range.

Question 6

What do analysts say about HUM?

Accepted Answer

Analysts currently rate Humana Inc. as Hold. Coverage is updated daily from major firms.

Question 7

Does HUM pay a dividend?

Accepted Answer

Yes, Humana Inc. (HUM) pays a dividend with a current yield of 0.86%. This means for every $1,000 invested, you would receive approximately $8.65 per year in dividends.

Question 8

Is HUM revenue growing?

Accepted Answer

Humana Inc. has a year-over-year revenue growth rate of +23.5%. This indicates strong growth momentum.

Question 9

What sector is HUM in?

Accepted Answer

Humana Inc. (HUM) operates in the Healthcare sector within the Medical - Healthcare Plans industry. You can explore other stocks in this sector on our Healthcare sector page.

Question 10

How has HUM performed this year?

Accepted Answer

Humana Inc. (HUM) has a year-to-date return of +59.9%. This significantly outperforms the broader market.

Question 11

Is HUM overvalued or undervalued?

Accepted Answer

Humana Inc. has a forward P/E ratio of 32.9 compared to its trailing P/E of 42.1. A lower forward P/E suggests analysts expect earnings growth. Visit the HUM stock page for detailed valuation analysis.

Humana Inc.

Price chart

Price performance

The thesis at a glance

Who's buying HUM right now

Latest print - beat on both lines

17 analysts · 29% Buy

How HUM stacks vs Medical - Healthcare Plans

Peers & themes